ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AGTRAP | Angiotensin II receptor-associated protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AKAP10 | A kinase (PRKA) anchor protein 10 | Disease related genes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
APOA1BP | Apolipoprotein A-I binding protein | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BAG6 | BCL2-associated athanogene 6 | | | | | | Expressed in all |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf56 | Chromosome 1 open reading frame 56 | Predicted secreted proteins
| | | | | Tissue enriched |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CADM1 | Cell adhesion molecule 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CALU | Calumenin | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CCDC112 | Coiled-coil domain containing 112 | Predicted secreted proteins
| | | | | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD4 | CD4 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CDC45 | Cell division cycle 45 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CGB2 | Chorionic gonadotropin, beta polypeptide 2 | Predicted secreted proteins
| | | | | Tissue enriched |
CGB8 | Chorionic gonadotropin, beta polypeptide 8 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CLGN | Calmegin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL8A1 | Collagen, type VIII, alpha 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRY2 | Cryptochrome 2 (photolyase-like) | Predicted secreted proteins
| | | | | Expressed in all |
CTSA | Cathepsin A | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
CTSS | Cathepsin S | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CTSZ | Cathepsin Z | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CX3CL1 | Chemokine (C-X3-C motif) ligand 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CXADR | Coxsackie virus and adenovirus receptor | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
DDOST | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DDX20 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 | Cytoskeleton related proteins Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DFNA5 | Deafness, autosomal dominant 5 | Disease related genes Predicted secreted proteins
| | | | | Mixed |
DIABLO | Diablo, IAP-binding mitochondrial protein | Disease related genes Mitochondrial proteins Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DKK3 | Dickkopf WNT signaling pathway inhibitor 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DNAJB11 | DnaJ (Hsp40) homolog, subfamily B, member 11 | Predicted secreted proteins
| | | | | Expressed in all |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DSG2 | Desmoglein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
EBAG9 | Estrogen receptor binding site associated, antigen, 9 | Cancer-related genes Predicted secreted proteins
| | | | | Expressed in all |
ECSIT | ECSIT signalling integrator | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |